Cité dans 2 publications.
Cet anticorps anti-LBP Monoclonal Souris (Clone biG33) (ABIN343173) détecte spécifiquement LBP dans ELISA.
L’anticorps est réactif avec des échantillons de Souris.
ELISA ,LBP inhibition studies, Western Blot. inhibits binding of LPS to membrane bound CD14, (Inhibits LPS-binding (0.5 ug/ml) to CD14+CHO cells (2 x 106/ml) up to 1:1000, total inhibition 1:5 Binding titre at mouse LBP- ELISA: 1:50.000 Cross reacting with rat LBP
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Reconstitute with bidistilled water
Concentration
1 mg/mL
Buffer
PBS, pH 7.17
Agent conservateur
Without preservative
Stock
-20 °C,-80 °C
Dziarski, Tapping, Tobias: "Binding of bacterial peptidoglycan to CD14." dans: The Journal of biological chemistry, Vol. 273, Issue 15, pp. 8680-90, (1998) (PubMed).
Weidemann, Schletter, Dziarski, Kusumoto, Stelter, Rietschel, Flad, Ulmer: "Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes." dans: Infection and immunity, Vol. 65, Issue 3, pp. 858-64, (1997) (PubMed).
Antigène
LBP
(Lipopolysaccharide Binding Protein (LBP))
Autre désignation
Lipopolysaccharide (LPS)-Binding Protein (LBP)
Sujet
Background: Natural LBP is a 58KD glycoprotein produced in liver. It binds at lipid A of LPS with high affinity (10-9M) and reduced the cellular LPS effects at CD14+ cells (IL1ß, IL6, TNFα). It acts as opsonin for GRAM negative cells, LPS, neutrophiles and granulocytes.